Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
TG Therapeutics, Inc. - Common Stock
(NQ:
TGTX
)
29.05
+0.63 (+2.22%)
Streaming Delayed Price
Updated: 12:32 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about TG Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
What's Next: TG Therapeutics's Earnings Preview
↗
August 01, 2025
Via
Benzinga
TG THERAPEUTICS INC (NASDAQ:TGTX) – A High Growth Momentum Stock with Strong Technical Setup
↗
July 17, 2025
TG THERAPEUTICS INC (NASDAQ:TGTX) shows strong earnings momentum and a bullish technical setup, making it a candidate for high-growth investors. The stock has solid revenue growth, improving margins,...
Via
Chartmill
TG THERAPEUTICS INC (NASDAQ:TGTX) - A High-Growth Stock Meeting Minervini's Trend Template
↗
July 12, 2025
TG Therapeutics (TGTX) meets Minervini's Trend Template with strong technicals and high-growth fundamentals, including 1,300% EPS growth and 90% revenue expansion. A breakout above $37.27 could signal...
Via
Chartmill
Cramer Backs This Mining Giant After $1.6B Bet
↗
July 01, 2025
Jim Cramer recommends buying Rio Tinto due to its high yield. TG Therapeutics is also a buy, with strong first-quarter sales and potential for market share growth.
Via
Benzinga
TG THERAPEUTICS INC (NASDAQ:TGTX) - A High Growth Momentum Stock with Strong Technical Setup
↗
June 25, 2025
TG Therapeutics (TGTX) shows strong earnings momentum with 142% EPS growth and a bullish technical setup, making it a candidate for high-growth investors.
Via
Chartmill
Earnings Scheduled For May 5, 2025
↗
May 05, 2025
Via
Benzinga
Why TG Therapeutics Stock Was Soaring This Week
↗
March 07, 2025
Via
The Motley Fool
Expert Outlook: TG Therapeutics Through The Eyes Of 5 Analysts
↗
January 15, 2025
Via
Benzinga
TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook
↗
May 05, 2025
Investors are optimistic about the company’s prospects, particularly in the multiple sclerosis market, despite challenges from competitors.
Via
Stocktwits
TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show
↗
May 05, 2025
TG Therapeutics posts Q1 profit and nearly doubles revenue, driven by rising Briumvi sales and higher full-year guidance for 2025.
Via
Benzinga
Why TG Therapeutics Stock Was Tumbling Today
↗
May 05, 2025
Via
The Motley Fool
Crude Oil Falls Over 2%; ISM Services PMI Rises In April
↗
May 05, 2025
Via
Benzinga
TG Therapeutics Stock Tumbles After Q1 Earnings Fall Short Of Wall Street Estimates: But Retail’s Optimistic
↗
May 05, 2025
The company, however, raised its full-year 2025 global net revenue target to approximately $575 million, up from its previous guidance of $540 million.
Via
Stocktwits
Applying Mark Minervini’s growth stock checklist to TG THERAPEUTICS INC (NASDAQ:TGTX)
↗
May 02, 2025
A fundamental and technical analysis of (NASDAQ:TGTX): Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for high growth investing?
Via
Chartmill
TG Therapeutics Inc (NASDAQ:TGTX): A Strong Minervini Trend Template Candidate
↗
May 01, 2025
TG Therapeutics Inc (NASDAQ:TGTX): A Strong Minervini Trend Template Candidate
Via
Chartmill
Exploring high growth characteristics of TG THERAPEUTICS INC (NASDAQ:TGTX).
↗
April 19, 2025
UA fundamental and technical analysis of (NASDAQ:TGTX): nlocking the high Growth Potential of TG THERAPEUTICS INC (NASDAQ:TGTX).
Via
Chartmill
Price Over Earnings Overview: TG Therapeutics
↗
April 14, 2025
Via
Benzinga
Applying Mark Minervini’s growth stock checklist to TG THERAPEUTICS INC (NASDAQ:TGTX)
↗
April 05, 2025
Why TG THERAPEUTICS INC (NASDAQ:TGTX) qualifies as a high growth stock. A fundamental and technical analysis of (NASDAQ:TGTX).
Via
Chartmill
IBD 50 Stock TG Therapeutics Rallies On A Setback For Chief Rival Roche
↗
April 02, 2025
The companies both have drugs that treat relapsing forms of multiple sclerosis.
Via
Investor's Business Daily
Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher
↗
March 21, 2025
TG Therapeutics has broken an important resistance level. There is a good chance that they will continue to move higher.
Via
Benzinga
How does TG THERAPEUTICS INC (NASDAQ:TGTX) stack up against Mark Minervini’s strategy?
↗
March 14, 2025
A fundamental and technical analysis of (NASDAQ:TGTX): Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for high growth investing?
Via
Chartmill
TG THERAPEUTICS INC (NASDAQ:TGTX), a growth stock which is not overvalued.
↗
March 10, 2025
Uncover the potential of TG THERAPEUTICS INC, a growth stock reasonably priced. NASDAQ:TGTX is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive...
Via
Chartmill
Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio?
↗
March 09, 2025
Top mid-cap stocks jumped up to 23.87%. Some reasons include strong gold/silver, better financial results, and market strength.
Via
Benzinga
Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week
↗
March 03, 2025
Annual revenue from its MS drug, Briumvi, more than tripled, with U.S. net product revenue reaching $103.6 million in the fourth quarter and $310 million for the full year.
Via
Stocktwits
Stocks Pivot Lower On Trade Fears, Manufacturing Data
↗
March 03, 2025
Despite earlier indicating a strong start to March, stocks are lower this afternoon amid trade war concerns.
Via
Talk Markets
Topics
Stocks / Equities
World Trade
TG Therapeutics, A New Leaderboard Stock, Skyrockets 17% On Sales Beat, Bullish Guide
↗
March 03, 2025
The company has gained notoriety for its multiple sclerosis treatment.
Via
Investor's Business Daily
Topics
Earnings
Earnings Scheduled For March 3, 2025
↗
March 03, 2025
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
February 26, 2025
Via
Benzinga
8 Health Care Stocks Whale Activity In Today's Session
↗
January 20, 2025
Via
Benzinga
What's Going On With TG Therapeutics Stock Tuesday?
↗
January 14, 2025
TG Therapeutics Inc (NASDAQ:TGTX) shares are trading higher. The company on Tuesday provided guidance for the fourth quarter and full-year 2024.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
